-
-
-
-
-
-
-
Biodesix publishes lung nodule biomarker validation study on 1,100 patients
-
-
-
-
-
-
-
Biodesix Inc. (BDSX) Misses Q3 EPS by 110c
-
-
-
-
-
-
-
Biodesix (BDSX) PT Lowered to $1.50 at Canaccord Genuity
-
-
-
-
-
446,353 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

